Press Room

Share

Failure to Override President's Veto Could Jeopardize Progress in the Fight Against Cancer

November 16, 2007

WASHINGTON, D.C. -- November 16, 2007 -- “Cancer patients and their loved ones are frustrated and disappointed that Congress fell short of the two-thirds majority needed to override the president’s veto of the Labor HHS appropriations bill that includes funds to provide for much needed increases in cancer research at the National Institutes of Health (NIH).

“After years of cut or flat funding, existing research projects are in danger of being shut down and new research endeavors could struggle to get needed resources, making it difficult to get critical prevention, detection and treatment measures from the labs to the doctors’ offices and the patients who need them most.

"The President's demand to reduce government spending should not come at the expense of cancer patients and their families. His plan would short critical NIH research funding by $1.4 billion from the amount passed by strong majorities in both the House and Senate. Now Congress needs to stand by that commitment and send the President a bill that gives hope to families in cancer’s path. “Cancer patients and their families are counting on the promise of groundbreaking research to save their lives. The time to fund the fight against cancer is now.”

ACS CAN is the nonprofit, nonpartisan sister advocacy organization of the American Cancer Society, dedicated to eliminating cancer as a major health problem. ACS CAN works to encourage lawmakers, candidates and government officials to support laws and policies that will make cancer a top national priority. ACS CAN gives ordinary people extraordinary power to fight cancer. For more information, visit www.fightcancer.org.

FOR MORE INFORMATION, CONTACT:
Alissa Havens
Phone: (202) 661-5772
Email: [email protected]

Steve Weiss
Phone: (202) 661-5711
Email: [email protected]

More Press Releases AboutCancer Research Funding

Related Press Releases

March 21, 2024

Congress Considers FY24 Appropriations Bill That Prioritizes Cancer Research and Proven Cancer Screening Funding Amidst Difficult Budget Cycle

WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion. At NIH, the bill also includes a first-time appropriation of $12.5 million in dedicated funding for the development of palliative care research at NIH and a new $6 million initiative for Improving Native American Cancer Outcomes. Within the Department of Defense (DoD), the bill includes a $110 million for the Prostate Cancer Research Program. 

Read More
March 24, 2023

New Jersey is taking a giant leap forward in the war against cancer. Here's how

The following originally appeared in the Asbury Park Press on March 24, 2023.

 

Read more
March 11, 2024

President’s FY25 Budget Prioritizes Funding for Cancer Research and Prevention

The American Cancer Society Cancer Action Network (ACS CAN) is pleased to see President Biden’s continued focus on and dedication to achieving the goal of the Cancer Moonshot to end cancer as we know it, for everyone.

Read more